EMAIL DETAILS

Eric and Rob,

Thanks for taking the time on Wednesday to meet our lead scientists and
hear our company story. Later this week I'll be sending out our series "B"
financing pitch book which will provide the company's detailed growth plans
for the next 18-24 months (and I also hope to complete our long awaited
rebranding this week!). Neil Callahan and I are scheduled to speak on
Friday but if I can provide any additional information regarding our
company, please don't hesitate to ask.

Thanks again for accommodating us and I look forward to our continued
discussions.

Best regards,

Michael

Michael Solimene
Chief Executive Officer
Avjet Biotech, Inc
203-257-433